| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8653089 | The Annals of Thoracic Surgery | 2017 | 10 Pages |
Abstract
In a national-level analysis, the use of adjuvant chemotherapy postoperatively in patients with pN+ and pN0 disease conferred no survival advantage; further study is needed to determine proper chemotherapy use for these patients.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Kevin L. MHSc, Michael S. MD, Paul J. MD, Babatunde A. MD, Brian C. MD, Daniel P. MD, David H. MD, Thomas A. MD, Mark F. MD, Matthew G. MD,